Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 1/2020

01-02-2020 | Ultrasound | Case Report

Contrast–enhanced endoscopic ultrasound diagnosis of the intraductal papillary mucinous neoplasm

Authors: Giovanna Del Vecchio Blanco, Cristina Gesuale, Alessandro Anselmo, Giampiero Palmieri, Francesca Baciorri, Monia Di Prete, Giuseppe Tisone, Giovanni Monteleone, Omero Alessandro Paoluzi

Published in: Clinical Journal of Gastroenterology | Issue 1/2020

Login to get access

Abstract

Pancreatic cystic neoplasms (PCNs) are a frequent incidental finding during an ultrasound or other radiological investigations. As PCNs may have a potential of malignancy, a precise differential diagnosis between a malignant and benign lesion is crucial to define appropriate management of patients with this kind of lesions. Radiology, with computed tomography (CT) and magnetic resonance imaging, may not be conclusive in the diagnostic assessment of PCNs. Endoscopic ultrasound (EUS), a simple and relatively low invasive technique, is able to identify intra-cystic worrisome features suggesting malignancy. Fine-needle aspiration (FNA) of the cystic fluid or of intra-cystic tissue nodule during EUS is an adjunctive procedure for reaching a conclusive diagnosis. As EUS-FNA is burdened by complications, the use of intravenous contrast may increase the diagnostic accuracy of EUS allowing in many cases a correct diagnosis of PCN at high risk of malignancy, without additional risk of complication during the procedure. The present report deals with the case of a cystic lesion found by CT scan in the pancreatic head of a 59-year-old woman suffering from mild epigastric pain. Once submitted to EUS, malignant nature of PCN was suspected due to the finding of a typical worrisome feature, the presence of a mural nodule. The intravenous administration of contrast medium during the EUS confirmed malignancy and the patient was immediately sent to the surgeon for pancreatic resection. Histology revealed an intraductal papillary mucinous neoplasm, with areas of high-grade dysplasia in the main and secondary ducts, progressed toward an invasive carcinoma.
Literature
1.
go back to reference Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol. 2008;191:802–7.CrossRef Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol. 2008;191:802–7.CrossRef
2.
go back to reference Castellano-Megías VM, Andrés CI, López-Alonso G, et al. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol. 2014;6:311–24.CrossRef Castellano-Megías VM, Andrés CI, López-Alonso G, et al. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol. 2014;6:311–24.CrossRef
3.
go back to reference The European Study Group on Cystic Tumours of the pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804.CrossRef The European Study Group on Cystic Tumours of the pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804.CrossRef
4.
go back to reference Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249:628–34.CrossRef Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249:628–34.CrossRef
5.
go back to reference Italian Association of Hospital Gastroenterologists and Endoscopists, Italian Association for the Study of the Pancreas, Buscarini E, et al. Cystic Pancreatic Neoplasm Study Group. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis 2014;46:479–93. Italian Association of Hospital Gastroenterologists and Endoscopists, Italian Association for the Study of the Pancreas, Buscarini E, et al. Cystic Pancreatic Neoplasm Study Group. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis 2014;46:479–93.
6.
go back to reference Lafemina J, Katabi N, Klimstra D, et al. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 2013;20:440–7.CrossRef Lafemina J, Katabi N, Klimstra D, et al. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 2013;20:440–7.CrossRef
7.
go back to reference Kim MJ, Choi DW, Choi SH, et al. Surgical treatment of solid pseudopapillary neoplasms of the pancreas and risk factors for malignancy. Br J Surg. 2014;101:1266–71.CrossRef Kim MJ, Choi DW, Choi SH, et al. Surgical treatment of solid pseudopapillary neoplasms of the pancreas and risk factors for malignancy. Br J Surg. 2014;101:1266–71.CrossRef
8.
go back to reference Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.CrossRef Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.CrossRef
9.
go back to reference Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–9.CrossRef Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–9.CrossRef
10.
go back to reference Distler M, Kersting S, Niedergethmann M, et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2013;258:324–30.CrossRef Distler M, Kersting S, Niedergethmann M, et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2013;258:324–30.CrossRef
11.
go back to reference Nakai Y, Isayama H, Itoi T, et al. Role of endoscopic ultrasonography in pancreatic cystic neoplasms: where do we stand and where will we go? Dig Endosc. 2014;26:135–43.CrossRef Nakai Y, Isayama H, Itoi T, et al. Role of endoscopic ultrasonography in pancreatic cystic neoplasms: where do we stand and where will we go? Dig Endosc. 2014;26:135–43.CrossRef
12.
go back to reference Barresi L, Tarantino I, Granata A, et al. Pancreatic cystic lesions: how endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle. World J Gastrointest Endosc. 2012;4:247–59.CrossRef Barresi L, Tarantino I, Granata A, et al. Pancreatic cystic lesions: how endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle. World J Gastrointest Endosc. 2012;4:247–59.CrossRef
13.
go back to reference Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33:33–59.CrossRef Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33:33–59.CrossRef
14.
go back to reference Ohno E, Itoh A, Kawashima H, et al. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast–enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself. Pancreas. 2012;41:855–62.CrossRef Ohno E, Itoh A, Kawashima H, et al. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast–enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself. Pancreas. 2012;41:855–62.CrossRef
15.
go back to reference Yamashita Y, Ueda K, Itonaga M, et al. Usefulness of contrast–enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms: a single-center prospective study. J Ultrasound Med. 2013;32:61–8.CrossRef Yamashita Y, Ueda K, Itonaga M, et al. Usefulness of contrast–enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms: a single-center prospective study. J Ultrasound Med. 2013;32:61–8.CrossRef
16.
go back to reference Hocke M, Cui XW, Domagk D, et al. Pancreatic cystic lesions: the value of contrast–enhanced endoscopic ultrasound to influence the clinical pathway. Endosc Ultrasound. 2014;3:123–30.CrossRef Hocke M, Cui XW, Domagk D, et al. Pancreatic cystic lesions: the value of contrast–enhanced endoscopic ultrasound to influence the clinical pathway. Endosc Ultrasound. 2014;3:123–30.CrossRef
17.
go back to reference Harima H, Kaino S, Shinoda S, et al. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast–enhanced endoscopic ultrasonography. World J Gastroenterol. 2015;21:6252–60.CrossRef Harima H, Kaino S, Shinoda S, et al. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast–enhanced endoscopic ultrasonography. World J Gastroenterol. 2015;21:6252–60.CrossRef
18.
go back to reference Kamata K, Kitano M, Omoto S, et al. Contrast–enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy. 2016;48:35–41.CrossRef Kamata K, Kitano M, Omoto S, et al. Contrast–enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy. 2016;48:35–41.CrossRef
19.
go back to reference Fusaroli P, Serrani M, De Giorgio R, et al. Contrast harmonic–endoscopic ultrasound is useful to identify neoplastic features of pancreatic cysts. Pancreas. 2016;45:265–8.CrossRef Fusaroli P, Serrani M, De Giorgio R, et al. Contrast harmonic–endoscopic ultrasound is useful to identify neoplastic features of pancreatic cysts. Pancreas. 2016;45:265–8.CrossRef
20.
go back to reference Fujita M, Itoi T, Ikeuchi N, et al. Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions. Endosc Ultrasound. 2016;5:377–83.CrossRef Fujita M, Itoi T, Ikeuchi N, et al. Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions. Endosc Ultrasound. 2016;5:377–83.CrossRef
21.
go back to reference ASGE Standards of Practice Committee, Early DS, Acosta RD, et al. Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc. 2013;77:839–43.CrossRef ASGE Standards of Practice Committee, Early DS, Acosta RD, et al. Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc. 2013;77:839–43.CrossRef
22.
go back to reference Faias S, Duarte M, Albuquerque C, et al. Clinical impact of KRAS and GNAS analysis added to CEA and cytology in pancreatic cystic fluid obtained by EUS-FNA. Dig Dis Sci. 2018;63:2351–61.CrossRef Faias S, Duarte M, Albuquerque C, et al. Clinical impact of KRAS and GNAS analysis added to CEA and cytology in pancreatic cystic fluid obtained by EUS-FNA. Dig Dis Sci. 2018;63:2351–61.CrossRef
23.
go back to reference Polkowski M, Larghi A, Weynand B, et al. Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline. Endoscopy. 2012;44:190–206.CrossRef Polkowski M, Larghi A, Weynand B, et al. Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline. Endoscopy. 2012;44:190–206.CrossRef
24.
go back to reference Vilas-Boas F, Macedo G. Pancreatic cystic lesions: new endoscopic trends in diagnosis. J Clin Gastroenterol. 2018;52:13–9.CrossRef Vilas-Boas F, Macedo G. Pancreatic cystic lesions: new endoscopic trends in diagnosis. J Clin Gastroenterol. 2018;52:13–9.CrossRef
25.
go back to reference Jonkman EF, van Tuyl BA, Sanders FB, et al. Severe acute pancreatitis after EUS-FNA of a pancreatic cyst: a rare, but serious complication BMJ Case Rep 2015;2015:bcr2015209442. Jonkman EF, van Tuyl BA, Sanders FB, et al. Severe acute pancreatitis after EUS-FNA of a pancreatic cyst: a rare, but serious complication BMJ Case Rep 2015;2015:bcr2015209442.
Metadata
Title
Contrast–enhanced endoscopic ultrasound diagnosis of the intraductal papillary mucinous neoplasm
Authors
Giovanna Del Vecchio Blanco
Cristina Gesuale
Alessandro Anselmo
Giampiero Palmieri
Francesca Baciorri
Monia Di Prete
Giuseppe Tisone
Giovanni Monteleone
Omero Alessandro Paoluzi
Publication date
01-02-2020
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 1/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01008-3

Other articles of this Issue 1/2020

Clinical Journal of Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine